Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Wordsworth

Showing results (61-70 of 141) with videos related to

Pageof 15
Sort By:
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 28, 2018
Reducing demand for antibiotic prescriptions: evidence from an online survey of the general public on the interaction between preferences, beliefs and information, United Kingdom, 2015Laurence S J Roope, Sarah Tonkin-Crine, Christopher C Butler, et al.
BMC Cancer|April 27, 2022
Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patientsApostolos Tsiachristas, Grant Vallance, Rositsa Koleva-Kolarova, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus SurveyJoanna C Thorn, Sara T Brookes, Colin Ridyard, et al.
Applied Health Economics and Health Policy|February 23, 2026
Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health InterventionsRositsa Koleva-Kolarova, Emily Hulse, Bertalan Németh, et al.
Journal of Cardiothoracic Surgery|March 27, 2021
Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO)Espeed Khoshbin, Sally Spencer, Laurence Solomon, et al.
Pharmacoeconomics|April 16, 2021
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised MedicineHeleen Vellekoop, Simone Huygens, Matthijs Versteegh, et al.
BMJ Open|July 14, 2019
Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UKElizabeth A Stokes, Brett Doble, Maria Pufulete, et al.
Personalized Medicine|September 4, 2023
Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countriesLászló Szilberhorn, Tamás Zelei, Heleen Vellekoop, et al.
Personalized Medicine|September 11, 2023
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studiesBalázs Nagy, Tamás Zelei, Heleen Vellekoop, et al.
Personalized Medicine|August 25, 2023
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementationRositsa Koleva-Kolarova, László Szilberhorn, Tamás Zelei, et al.
Pageof 15

Showing results (61-70 of 141) with videos related to

Sort By:
Pageof 15
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|June 28, 2018
Reducing demand for antibiotic prescriptions: evidence from an online survey of the general public on the interaction between preferences, beliefs and information, United Kingdom, 2015Laurence S J Roope, Sarah Tonkin-Crine, Christopher C Butler, et al.
BMC Cancer|April 27, 2022
Can upfront DPYD extended variant testing reduce toxicity and associated hospital costs of fluoropyrimidine chemotherapy? A propensity score matched analysis of 2022 UK patientsApostolos Tsiachristas, Grant Vallance, Rositsa Koleva-Kolarova, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 19, 2018
Core Items for a Standardized Resource Use Measure: Expert Delphi Consensus SurveyJoanna C Thorn, Sara T Brookes, Colin Ridyard, et al.
Applied Health Economics and Health Policy|February 23, 2026
Towards a Multi-sectoral Approach to Population Health: A Scoping Review of Cross-sectoral Evaluations of Health InterventionsRositsa Koleva-Kolarova, Emily Hulse, Bertalan Németh, et al.
Journal of Cardiothoracic Surgery|March 27, 2021
Is there a renoprotective value to leukodepletion during heart valve surgery? A randomized controlled trial (ROLO)Espeed Khoshbin, Sally Spencer, Laurence Solomon, et al.
Pharmacoeconomics|April 16, 2021
Guidance for the Harmonisation and Improvement of Economic Evaluations of Personalised MedicineHeleen Vellekoop, Simone Huygens, Matthijs Versteegh, et al.
BMJ Open|July 14, 2019
Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UKElizabeth A Stokes, Brett Doble, Maria Pufulete, et al.
Personalized Medicine|September 4, 2023
Cost-effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countriesLászló Szilberhorn, Tamás Zelei, Heleen Vellekoop, et al.
Personalized Medicine|September 11, 2023
Lessons learned from the application of the HEcoPerMed guidance to three modeling case studiesBalázs Nagy, Tamás Zelei, Heleen Vellekoop, et al.
Personalized Medicine|August 25, 2023
Financial incentives to promote personalized medicine in Europe: an overview and guidance for implementationRositsa Koleva-Kolarova, László Szilberhorn, Tamás Zelei, et al.
Pageof 15